While a trend towards increased CD8+ cell recruitement was observed under TAX2 treatment (Figure 4g), TAX2 did not impact macrophages tumor recruitment from peritumoral areas (Figure 4h), thereby demonstrating that TAX2 effects are mostly focused on adaptive immunity modulation. The gene discussed is CD8A; the disease is neoplasm.